Lacey McNally to Mice
This is a "connection" page, showing publications Lacey McNally has written about Mice.
Connection Strength
1.258
-
Theranostic nanoparticles for detection and treatment of pancreatic cancer. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2024 Jul-Aug; 16(4):e1983.
Score: 0.120
-
Simultaneous Detection of Multiple Tumor-targeted Gold Nanoparticles in HER2-Positive Breast Tumors Using Optoacoustic Imaging. Radiol Imaging Cancer. 2023 05; 5(3):e220180.
Score: 0.111
-
Active Targeting Significantly Outperforms Nanoparticle Size in Facilitating Tumor-Specific Uptake in Orthotopic Pancreatic Cancer. ACS Appl Mater Interfaces. 2021 Oct 27; 13(42):49614-49630.
Score: 0.100
-
Osteopontin-targeted probe detects orthotopic breast cancers using optoacoustic imaging. Biotech Histochem. 2018; 93(8):608-614.
Score: 0.081
-
Optoacoustic imaging identifies ovarian cancer using a microenvironment targeted theranostic wormhole mesoporous silica nanoparticle. Biomaterials. 2018 11; 182:114-126.
Score: 0.080
-
Detection of microspheres in vivo using multispectral optoacoustic tomography. Biotech Histochem. 2017; 92(1):1-6.
Score: 0.072
-
Noninvasive Imaging of Colitis Using Multispectral Optoacoustic Tomography. J Nucl Med. 2017 06; 58(6):1009-1012.
Score: 0.071
-
Identification of pancreatic tumors in vivo with ligand-targeted, pH responsive mesoporous silica nanoparticles by multispectral optoacoustic tomography. J Control Release. 2016 06 10; 231:60-7.
Score: 0.067
-
Tumor specific liposomes improve detection of pancreatic adenocarcinoma in vivo using optoacoustic tomography. J Nanobiotechnology. 2015 Dec 01; 13:90.
Score: 0.066
-
Targeting Acidity in Pancreatic Adenocarcinoma: Multispectral Optoacoustic Tomography Detects pH-Low Insertion Peptide Probes In Vivo. Clin Cancer Res. 2015 Oct 15; 21(20):4576-85.
Score: 0.064
-
Orthotopic pancreatic tumors detected by optoacoustic tomography using Syndecan-1. J Surg Res. 2015 Jan; 193(1):246-54.
Score: 0.061
-
Targeted noninvasive imaging of EGFR-expressing orthotopic pancreatic cancer using multispectral optoacoustic tomography. Cancer Res. 2014 Nov 01; 74(21):6271-9.
Score: 0.061
-
Targeting of BRAF resistant melanoma via extracellular matrix metalloproteinase inducer receptor. J Surg Res. 2014 Jul; 190(1):111-8.
Score: 0.059
-
KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse model. Clin Exp Metastasis. 2010 Dec; 27(8):591-600.
Score: 0.046
-
Therapy of head and neck squamous cell carcinoma with replicative adenovirus expressing tissue inhibitor of metalloproteinase-2 and chemoradiation. Cancer Gene Ther. 2009 Mar; 16(3):246-55.
Score: 0.040
-
Improved pentamethine cyanine nanosensors for optoacoustic imaging of pancreatic cancer. Sci Rep. 2021 02 23; 11(1):4366.
Score: 0.024
-
Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer. Cell Death Differ. 2019 10; 26(10):2100-2114.
Score: 0.021
-
Dectin-1 Activation by a Natural Product ß-Glucan Converts Immunosuppressive Macrophages into an M1-like Phenotype. J Immunol. 2015 Nov 15; 195(10):5055-65.
Score: 0.016
-
Fusion of cell-penetrating peptides to thermally responsive biopolymer improves tumor accumulation of p21 peptide in a mouse model of pancreatic cancer. Drug Des Devel Ther. 2014; 8:1649-58.
Score: 0.015
-
Adenovirus-mediated FKHRL1/TM sensitizes melanoma cells to apoptosis induced by temozolomide. Hum Gene Ther Clin Dev. 2014 Sep; 25(3):186-95.
Score: 0.015
-
Predictive modeling of in vivo response to gemcitabine in pancreatic cancer. PLoS Comput Biol. 2013; 9(9):e1003231.
Score: 0.014
-
Anti-tumor activity of an anti-DR5 monoclonal antibody, TRA-8, in combination with taxane/platinum-based chemotherapy in an ovarian cancer model. Gynecol Oncol. 2011 Apr; 121(1):193-9.
Score: 0.012
-
Noninvasive monitoring of mRFP1- and mCherry-labeled oncolytic adenoviruses in an orthotopic breast cancer model by spectral imaging. Mol Imaging. 2010 Apr; 9(2):59-75.
Score: 0.011
-
Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancer. Clin Cancer Res. 2009 Jun 15; 15(12):4058-65.
Score: 0.011
-
In vivo efficacy of marimastat and chemoradiation in head and neck cancer xenografts. ORL J Otorhinolaryngol Relat Spec. 2009; 71(1):1-5.
Score: 0.010
-
Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging. Cancer Res. 2008 Oct 15; 68(20):8369-76.
Score: 0.010